Universal Ibogaine Inc (IBO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 04-2025 | 01-2025 | 10-2024 | 07-2024 | 04-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 80 | 89 | 80 | 97 | 80 |
| Accounts receivable | N/A | N/A | 55 | 24 | N/A |
| Other Working Capital | -130 | 11 | 12 | -119 | -92 |
| Other Operating Activity | -61 | -301 | -393 | -88 | -490 |
| Operating Cash Flow | $-110 | $-202 | $-246 | $-85 | $-501 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -1 | -20 | -19 |
| Investing Cash Flow | $0 | $0 | $-1 | $-20 | $-19 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -32 | -32 | -32 | -122 | -33 |
| Common Stock Issued | 0 | 0 | 0 | 130 | 993 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -327 |
| Other Financing Activity | -4 | 416 | 0 | -3 | -7 |
| Financing Cash Flow | $-36 | $384 | $-32 | $5 | $626 |
| Beginning Cash Position | 274 | 92 | 371 | 470 | 365 |
| End Cash Position | 128 | 274 | 92 | 371 | 470 |
| Net Cash Flow | $-146 | $182 | $-279 | $-99 | $106 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110 | -202 | -246 | -85 | -501 |
| Capital Expenditure | N/A | N/A | -1 | -20 | -19 |
| Free Cash Flow | -110 | -202 | -247 | -105 | -521 |